Printer Friendly
The Free Library
19,266,432 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AVANIR Pharmaceuticals Announces Exercise of Over-Allotment Option by Underwriter.


Business Editors/Health/Medical Writers

BIOWIRE2K

SAN DIEGO--(BUSINESS WIRE)--June 10, 2004

AVANIR Pharmaceuticals (AMEX AMEX

See: American Stock Exchange
:AVN AVN Aviation
AVN Avenue
AVN Adult Video News
AVN Avascular Necrosis
AVN Atrioventricular Node
AVN Aviation Model (weather forecast model, now Global Forecast System)
AVN Air Vanuatu (ICAO code) 
) today announced that the underwriter of its recently announced public offering has exercised its option to purchase an additional 2,952,756 shares of common stock from AVANIR at the public offering price of $1.27 per share to cover over-allotments. Including the over-allotment shares, 22,637,796 shares have been sold through the public offering, resulting in gross proceeds to the company of approximately $28,750,000.

Lazard Freres & Co. LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 acted as sole underwriter of the offering. Copies of the final prospectus Final Prospectus

A legal document stating the price of a newly issued security, the delivery date, and other facts that are important for investors.

Notes:
The final prospectus must be given to every investor who purchases a new issue of registered securities.
 may be obtained from the offices of Lazard Freres & Co. LLC, 30 Rockefeller Plaza, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
, NY 10020.

This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state.

AVANIR Pharmaceuticals, based in San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. , is a drug discovery and development company focused on the development of treatments for chronic diseases. Further information about AVANIR can be found at www.avanir.com.

The information contained in this press release, including any forward-looking statements contained herein, should be reviewed in conjunction with the company's most recent Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 and other publicly available information regarding the company. Copies of such information are available from the company upon request. Such publicly available information sets forth many risks and uncertainties related to the company's business and technology. Forward-looking statements often contain such words like "estimate," "anticipate," "believe," "plan" or "expect." The company disclaims any intent or obligation to update these forward-looking statements.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 10, 2004
Words:302
Previous Article:GeoGlobal Drilling Update.
Next Article:Anooraq and Pelawan Receive Letter of Final Approval from South African Reserve Bank.
Topics:



Related Articles
Eaton Vance Corp. Raises $1.55 Billion in Initial Public Offering of Three Closed-End Municipal Bond Funds.
Kerzner Announces Exercise of Over-Allotment.
Overallotment Option Exercised in Texas Capital Bancshares Initial Public Offering.
Harris & Harris Group, Inc. Announces the Exercise of the Overallotment Option and the Additional Sale of 300,000 Shares in Its Secondary Offering.
Company Watch - Continental Airlines.
ICF International Announces Full Exercise of Overallotment Option by Underwriters.
KBR Launches IPO Road Show.
Aradigm Closes Offering of Common Stock.
Altus Pharmaceuticals Announces Public Offering of Common Stock.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles